Bio-thera expands partnership with Intas for golimumab biosimilar
PositiveFinancial Markets

Bio-thera has announced an expansion of its partnership with Intas to develop a biosimilar for golimumab, a medication used to treat autoimmune diseases. This collaboration is significant as it aims to enhance access to affordable treatment options for patients, potentially improving health outcomes in the long run. The partnership reflects a growing trend in the pharmaceutical industry towards biosimilars, which can offer similar efficacy to original biologics at a lower cost.
— Curated by the World Pulse Now AI Editorial System